Patent · US Active

Pyrrolidinone derivatives as MetAP-2 inhibitors

US10005756B2 · kind B2 · utility

1Cited by

1References

8Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Timo Heinrich · Groß-Umstadt, DE
Frank Zenke · Darmstadt, DE
Felix Rohdich · Freising, DE
Manja Friese-Hamim · Mörfelden, DE
Diane Hahn · Otzberg, DE

Key dates

Filing date	Jul 10, 2015
Grant date	Jun 26, 2018
Priority date	—
Expiry date	Jul 10, 2035

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds according to Claim 1, are inhibitors of methionine aminopeptidase and can be employed for the treatment of tumors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.